Emami Share Price
Sector: Personal & Household Prods.
You have to be logged in to add this to Watchlist.
Login or Register
632.80 -11.55 (-1.79%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
618.2
Today’s High
650.05
52 Week Low
417.55
52 Week High
859.2
634.05 -9.10 (-1.41%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
618
Today’s High
643.45
52 Week Low
417.1
52 Week High
860
Key Metrics
- Market Cap (In Cr) 28073.5
- Beta 1.07
- Div. Yield (%) 1.24
- P/B 11.47
- TTM P/E 43.3
- Peg Ratio 2.09
- Sector P/E 50.47
- D/E 0.03
- Open Price 650.05
- Prev Close 644.35
Emami Analysis
Price Analysis
-
1 Week-4.69%
-
3 Months-19.56%
-
6 Month25.75%
-
YTD14.08%
-
1 Year30.73%
Risk Meter
- 42% Low risk
- 42% Moderate risk
- 42% Balanced Risk
- 42% High risk
- 42% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 10
- 10
- 9
- 9
- Buy
- 8
- 8
- 9
- 9
- Hold
- 6
- 6
- 6
- 6
- Sell
- 1
- 1
- 1
- 1
- Strong Sell
- 0
- 0
- 0
- 0
- Total
- 25
- 25
- 25
- 25
Emami News
Art Mumbai 2024: An emerging platform for contemporary South Asian voices
3 min read . 09 Nov 2024Emami Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 3578.09
- Selling/ General/ Admin Expenses Total
- 1047.84
- Depreciation/ Amortization
- 185.9
- Other Operating Expenses Total
- 420.18
- Total Operating Expense
- 2820.36
- Operating Income
- 757.73
- Net Income Before Taxes
- 790.83
- Net Income
- 723.53
- Diluted Normalized EPS
- 16.67
- Period
- 2024
- Total Assets
- 3279.7
- Total Liabilities
- 833.11
- Total Equity
- 2446.59
- Tangible Book Valueper Share Common Eq
- 45.42
- Period
- 2024
- Cashfrom Operating Activities
- 779
- Cashfrom Investing Activities
- -205.4
- Cashfrom Financing Activities
- -562.97
- Net Changein Cash
- 6.16
- Period
- 2023
- Total Revenue
- 3405.73
- Selling/ General/ Admin Expenses Total
- 1266.8
- Depreciation/ Amortization
- 230.03
- Other Operating Expenses Total
- 31.99
- Total Operating Expense
- 2783.04
- Operating Income
- 622.69
- Net Income Before Taxes
- 669.55
- Net Income
- 639.57
- Diluted Normalized EPS
- 14.74
- Period
- 2023
- Total Assets
- 3109.85
- Total Liabilities
- 807.05
- Total Equity
- 2302.8
- Tangible Book Valueper Share Common Eq
- 39.87
- Period
- 2023
- Cashfrom Operating Activities
- 751.98
- Cashfrom Investing Activities
- -112.83
- Cashfrom Financing Activities
- -607.64
- Net Changein Cash
- 19.21
- Period
- 2022
- Total Revenue
- 3192.03
- Selling/ General/ Admin Expenses Total
- 1097.1
- Depreciation/ Amortization
- 333.64
- Other Operating Expenses Total
- 24.62
- Total Operating Expense
- 2573.68
- Operating Income
- 618.35
- Net Income Before Taxes
- 688
- Net Income
- 838.98
- Diluted Normalized EPS
- 18.94
- Period
- 2022
- Total Assets
- 3057.48
- Total Liabilities
- 980.89
- Total Equity
- 2076.59
- Tangible Book Valueper Share Common Eq
- 33.8
- Period
- 2022
- Cashfrom Operating Activities
- 643.92
- Cashfrom Investing Activities
- -234.9
- Cashfrom Financing Activities
- -402.14
- Net Changein Cash
- 7.76
- Period
- 2021
- Total Revenue
- 2880.53
- Selling/ General/ Admin Expenses Total
- 1005.84
- Depreciation/ Amortization
- 365.85
- Other Operating Expenses Total
- 23.43
- Total Operating Expense
- 2356.39
- Operating Income
- 524.13
- Net Income Before Taxes
- 568.92
- Net Income
- 454.7
- Diluted Normalized EPS
- 10.25
- Period
- 2021
- Total Assets
- 2519.69
- Total Liabilities
- 757.04
- Total Equity
- 1762.65
- Tangible Book Valueper Share Common Eq
- 31.69
- Period
- 2021
- Cashfrom Operating Activities
- 921.53
- Cashfrom Investing Activities
- -226.95
- Cashfrom Financing Activities
- -688.18
- Net Changein Cash
- 8.97
- Period
- 2020
- Total Revenue
- 2654.88
- Selling/ General/ Admin Expenses Total
- 1021.33
- Depreciation/ Amortization
- 335.23
- Other Operating Expenses Total
- 27.88
- Total Operating Expense
- 2301.36
- Operating Income
- 353.52
- Net Income Before Taxes
- 373.57
- Net Income
- 302.91
- Diluted Normalized EPS
- 6.77
- Period
- 2020
- Total Assets
- 2678.48
- Total Liabilities
- 854.73
- Total Equity
- 1823.75
- Tangible Book Valueper Share Common Eq
- 26.56
- Period
- 2020
- Cashfrom Operating Activities
- 530.75
- Cashfrom Investing Activities
- -227.69
- Cashfrom Financing Activities
- -405.36
- Net Changein Cash
- -105.63
- Period
- 2019
- Total Revenue
- 2692.94
- Selling/ General/ Admin Expenses Total
- 984.17
- Depreciation/ Amortization
- 322.63
- Other Operating Expenses Total
- 25.92
- Total Operating Expense
- 2296.08
- Operating Income
- 396.86
- Net Income Before Taxes
- 403.41
- Net Income
- 303.23
- Diluted Normalized EPS
- 6.84
- Period
- 2019
- Total Assets
- 2822.37
- Total Liabilities
- 746.3
- Total Equity
- 2076.06
- Tangible Book Valueper Share Common Eq
- 26.41
- Period
- 2019
- Cashfrom Operating Activities
- 553.74
- Cashfrom Investing Activities
- -23.39
- Cashfrom Financing Activities
- -427.66
- Net Changein Cash
- 100.28
- Period
- 2018
- Total Revenue
- 2540.83
- Selling/ General/ Admin Expenses Total
- 943.63
- Depreciation/ Amortization
- 309.6
- Other Operating Expenses Total
- 29.2
- Total Operating Expense
- 2126.64
- Operating Income
- 414.19
- Net Income Before Taxes
- 393.77
- Net Income
- 307.14
- Diluted Normalized EPS
- 6.77
- Period
- 2018
- Total Assets
- 2800.74
- Total Liabilities
- 787.13
- Total Equity
- 2013.61
- Tangible Book Valueper Share Common Eq
- 22.12
- Period
- 2018
- Cashfrom Operating Activities
- 587.81
- Cashfrom Investing Activities
- -279.12
- Cashfrom Financing Activities
- -323.74
- Net Changein Cash
- -12.21
- Period
- 2024-09-30
- Total Revenue
- 890.59
- Selling/ General/ Admin Expenses Total
- 258.59
- Depreciation/ Amortization
- 44.65
- Other Operating Expenses Total
- 120.51
- Total Operating Expense
- 684.77
- Operating Income
- 205.82
- Net Income Before Taxes
- 220.43
- Net Income
- 212.66
- Diluted Normalized EPS
- 4.87
- Period
- 2024-09-30
- Total Assets
- 3593.7
- Total Liabilities
- 965
- Total Equity
- 2628.7
- Tangible Book Valueper Share Common Eq
- 50.92
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 399.1
- Cashfrom Investing Activities
- -288.72
- Cashfrom Financing Activities
- -88.98
- Net Changein Cash
- 16.13
- Period
- 2024-06-30
- Total Revenue
- 906.07
- Selling/ General/ Admin Expenses Total
- 294.75
- Depreciation/ Amortization
- 44.43
- Other Operating Expenses Total
- 101.84
- Total Operating Expense
- 733.99
- Operating Income
- 172.08
- Net Income Before Taxes
- 178.38
- Net Income
- 152.64
- Diluted Normalized EPS
- 3.5
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 891.24
- Selling/ General/ Admin Expenses Total
- 270.68
- Depreciation/ Amortization
- 48
- Other Operating Expenses Total
- 104.63
- Total Operating Expense
- 728.26
- Operating Income
- 162.98
- Net Income Before Taxes
- 169.23
- Net Income
- 148.9
- Diluted Normalized EPS
- 3.41
- Period
- 2024-03-31
- Total Assets
- 3279.7
- Total Liabilities
- 833.11
- Total Equity
- 2446.59
- Tangible Book Valueper Share Common Eq
- 45.42
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 779
- Cashfrom Investing Activities
- -205.4
- Cashfrom Financing Activities
- -562.97
- Net Changein Cash
- 6.16
- Period
- 2023-12-31
- Total Revenue
- 996.32
- Selling/ General/ Admin Expenses Total
- 267.81
- Depreciation/ Amortization
- 45.81
- Other Operating Expenses Total
- 102.43
- Total Operating Expense
- 733.16
- Operating Income
- 263.16
- Net Income Before Taxes
- 276.13
- Net Income
- 258.41
- Diluted Normalized EPS
- 6.05
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 864.87
- Selling/ General/ Admin Expenses Total
- 256.07
- Depreciation/ Amortization
- 46.09
- Other Operating Expenses Total
- 116.34
- Total Operating Expense
- 677.29
- Operating Income
- 187.58
- Net Income Before Taxes
- 195.82
- Net Income
- 178.5
- Diluted Normalized EPS
- 4.09
- Period
- 2023-09-30
- Total Assets
- 3319.4
- Total Liabilities
- 913.7
- Total Equity
- 2405.7
- Tangible Book Valueper Share Common Eq
- 43.7
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 372.36
- Cashfrom Investing Activities
- -149.04
- Cashfrom Financing Activities
- -182.15
- Net Changein Cash
- 37.58
- Period
- 2023-06-30
- Total Revenue
- 825.66
- Selling/ General/ Admin Expenses Total
- 253.28
- Depreciation/ Amortization
- 46
- Other Operating Expenses Total
- 96.78
- Total Operating Expense
- 681.65
- Operating Income
- 144.01
- Net Income Before Taxes
- 149.65
- Net Income
- 137.72
- Diluted Normalized EPS
- 3.13
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 835.95
- Selling/ General/ Admin Expenses Total
- 221.73
- Depreciation/ Amortization
- 63.97
- Other Operating Expenses Total
- 106.24
- Total Operating Expense
- 700.11
- Operating Income
- 135.84
- Net Income Before Taxes
- 147.87
- Net Income
- 144.43
- Diluted Normalized EPS
- 3.28
- Period
- 2023-03-31
- Total Assets
- 3109.85
- Total Liabilities
- 807.05
- Total Equity
- 2302.8
- Tangible Book Valueper Share Common Eq
- 39.87
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 751.98
- Cashfrom Investing Activities
- -112.83
- Cashfrom Financing Activities
- -607.64
- Net Changein Cash
- 19.21
- Period
- 2022-12-31
- Total Revenue
- 982.72
- Selling/ General/ Admin Expenses Total
- 246.69
- Depreciation/ Amortization
- 47.24
- Other Operating Expenses Total
- 106.25
- Total Operating Expense
- 735.71
- Operating Income
- 247.01
- Net Income Before Taxes
- 251.48
- Net Income
- 237.13
- Diluted Normalized EPS
- 5.37
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Emami Technical
Moving Average
SMA
- 5 Day647.75
- 10 Day663.25
- 20 Day665.7
- 50 Day717.72
- 100 Day752.9
- 300 Day632.2
Emami Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- P&G Hygiene & Health Care
- 15795.25
- -8.25
- -0.05
- 19017.13
- 15306.15
- 51272.55
- Gillette India
- 9167.65
- -119.45
- -1.29
- 10633.45
- 5914.95
- 29872.99
- Emami
- 632.8
- -11.55
- -1.79
- 859.2
- 417.55
- 27784.99
- Jyothy Labs
- 405.95
- 1.2
- 0.3
- 595
- 366.7
- 14906.83
- Welspun Living
- 147.7
- -0.85
- -0.57
- 213.1
- 122.6
- 14353.61
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- P&G Hygiene & Health Care
- 74.51
- 66.19
- 68.53
- 16.2
- Gillette India
- 71.82
- 31.15
- 36.1
- 14.45
- Emami
- 38.78
- 11.47
- 28.94
- 18.75
- Jyothy Labs
- 41.44
- 8.22
- 15.81
- 10.14
- Welspun Living
- 21.08
- 3.2
- 13.8
- 6.21
Emami Shareholding
Shareholding Pattern
*Promoter pledging: 4.47%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 07-Nov-24
- Quarterly Results & Interim Dividend
- 01-Aug-24
- Quarterly Results
- 29-May-24
- Audited Results
- 09-Feb-24
- Quarterly Results & 2nd Interim Dividend
- 06-Nov-23
- Quarterly Results & Interim Dividend
- 07-Aug-23
- Quarterly Results
- 25-May-23
- Audited Results
- 24-Mar-23
- Buy Back of Shares
- 03-Feb-23
- Quarterly Results & 2nd Interim Dividend
- 11-Nov-22
- Quarterly Results & Interim Dividend
- Meeting Date
- Announced on
- Purpose
- 27-Aug-24
- 02-Aug-24
- AGM
- 27-Jul-24
- 24-Jun-24
- POM
- 15-Jan-24
- 13-Dec-23
- POM
- 23-Aug-23
- 25-Jul-23
- AGM
- 28-Jun-22
- 25-May-22
- POM
- 29-Mar-22
- 24-Feb-22
- POM
- -
- 29-Mar-23
- Others
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 16-Oct-24
- 18-Nov-24
- 18-Nov-24
- 4
- 12-Jan-24
- 19-Feb-24
- 16-Feb-24
- 4
- 30-Oct-23
- 15-Nov-23
- 15-Nov-23
- 4
- 25-Jan-23
- 13-Feb-23
- 13-Feb-23
- 4
- 18-Oct-22
- 21-Nov-22
- 18-Nov-22
- 4
- 17-Jan-22
- 11-Feb-22
- 10-Feb-22
- 4
- 18-Oct-21
- 09-Nov-21
- 08-Nov-21
- 4
- 18-Jan-21
- 05-Feb-21
- 04-Feb-21
- 4